| pubmed-article:2642294 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2642294 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:2642294 | lifeskim:mentions | umls-concept:C1135183 | lld:lifeskim |
| pubmed-article:2642294 | lifeskim:mentions | umls-concept:C0022131 | lld:lifeskim |
| pubmed-article:2642294 | lifeskim:mentions | umls-concept:C0008524 | lld:lifeskim |
| pubmed-article:2642294 | lifeskim:mentions | umls-concept:C0023884 | lld:lifeskim |
| pubmed-article:2642294 | lifeskim:mentions | umls-concept:C0032923 | lld:lifeskim |
| pubmed-article:2642294 | lifeskim:mentions | umls-concept:C0597879 | lld:lifeskim |
| pubmed-article:2642294 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:2642294 | pubmed:dateCreated | 1989-1-24 | lld:pubmed |
| pubmed-article:2642294 | pubmed:abstractText | We examined transthyretin immunoreactivity (TTR-IR) in human and porcine liver, choroid plexus, and pancreatic islets with both polyclonal and monoclonal antibodies to TTR. The specificity of the immunoreactions and the effects of various fixatives were tested in immunohistochemical and dot-blot systems. B-5 fixative (mercuric chloride and sodium acetate in formalin) was the best immunopreservative. In both species, the TTR-IR in choroid plexus epithelial cells was strong and was much greater than that in hepatocytes. Glucagon cells in pancreatic islets were also strongly TTR immunoreactive. Insulin cells were slightly TTR immunoreactive in human but strongly so in porcine pancreas. The finding of TTR-IR in normal islets explains the presence of TTR-IR in human endocrine pancreatic tumors, notably glucagonomas and malignant insulinomas. | lld:pubmed |
| pubmed-article:2642294 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2642294 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2642294 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2642294 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2642294 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2642294 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2642294 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2642294 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:2642294 | pubmed:issn | 0022-1554 | lld:pubmed |
| pubmed-article:2642294 | pubmed:author | pubmed-author:GrimeliusLL | lld:pubmed |
| pubmed-article:2642294 | pubmed:author | pubmed-author:CollinsV PVP | lld:pubmed |
| pubmed-article:2642294 | pubmed:author | pubmed-author:PetterssonTT | lld:pubmed |
| pubmed-article:2642294 | pubmed:author | pubmed-author:CarlströmAA | lld:pubmed |
| pubmed-article:2642294 | pubmed:author | pubmed-author:SandstedtBB | lld:pubmed |
| pubmed-article:2642294 | pubmed:author | pubmed-author:JacobssonBB | lld:pubmed |
| pubmed-article:2642294 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2642294 | pubmed:volume | 37 | lld:pubmed |
| pubmed-article:2642294 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2642294 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2642294 | pubmed:pagination | 31-7 | lld:pubmed |
| pubmed-article:2642294 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2642294 | pubmed:meshHeading | pubmed-meshheading:2642294-... | lld:pubmed |
| pubmed-article:2642294 | pubmed:meshHeading | pubmed-meshheading:2642294-... | lld:pubmed |
| pubmed-article:2642294 | pubmed:meshHeading | pubmed-meshheading:2642294-... | lld:pubmed |
| pubmed-article:2642294 | pubmed:meshHeading | pubmed-meshheading:2642294-... | lld:pubmed |
| pubmed-article:2642294 | pubmed:meshHeading | pubmed-meshheading:2642294-... | lld:pubmed |
| pubmed-article:2642294 | pubmed:meshHeading | pubmed-meshheading:2642294-... | lld:pubmed |
| pubmed-article:2642294 | pubmed:meshHeading | pubmed-meshheading:2642294-... | lld:pubmed |
| pubmed-article:2642294 | pubmed:meshHeading | pubmed-meshheading:2642294-... | lld:pubmed |
| pubmed-article:2642294 | pubmed:meshHeading | pubmed-meshheading:2642294-... | lld:pubmed |
| pubmed-article:2642294 | pubmed:meshHeading | pubmed-meshheading:2642294-... | lld:pubmed |
| pubmed-article:2642294 | pubmed:meshHeading | pubmed-meshheading:2642294-... | lld:pubmed |
| pubmed-article:2642294 | pubmed:meshHeading | pubmed-meshheading:2642294-... | lld:pubmed |
| pubmed-article:2642294 | pubmed:meshHeading | pubmed-meshheading:2642294-... | lld:pubmed |
| pubmed-article:2642294 | pubmed:meshHeading | pubmed-meshheading:2642294-... | lld:pubmed |
| pubmed-article:2642294 | pubmed:meshHeading | pubmed-meshheading:2642294-... | lld:pubmed |
| pubmed-article:2642294 | pubmed:year | 1989 | lld:pubmed |
| pubmed-article:2642294 | pubmed:articleTitle | Transthyretin immunoreactivity in human and porcine liver, choroid plexus, and pancreatic islets. | lld:pubmed |
| pubmed-article:2642294 | pubmed:affiliation | Department of Pathology, Danderyd Hospital, Sweden. | lld:pubmed |
| pubmed-article:2642294 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2642294 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2642294 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2642294 | lld:pubmed |
